Clinical trial
Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders…
NCT00484029 · Capnia, Inc., Industry · Completed
Key facts
| NCT number | NCT00484029 |
|---|---|
| Title | Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain |
| Official title | A Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Nasal CO2 in the Symptomatic Treatment of Temporomandibular Disorders |
| Lead sponsor | Capnia, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Temporomandibular Disorders, Pain, Headaches |
| Intervention type | Drug, Other |
| Interventions | Nasal Carbon Dioxide, Air |
| Enrollment | 100 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 8, 2007 |
| Last update posted | Aug 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: